Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

Luteinizing hormone inhibits Fas-induced apoptosis in ovarian surface epithelial cell lines.

Slot KA, de Boer-Brouwer M, Houweling M, Vaandrager AB, Dorrington JH, Teerds KJ.

J Endocrinol. 2006 Feb;188(2):227-39.

2.

Estrous cycle dependent changes in expression and distribution of Fas, Fas ligand, Bcl-2, Bax, and pro- and active caspase-3 in the rat ovary.

Slot KA, Voorendt M, de Boer-Brouwer M, van Vugt HH, Teerds KJ.

J Endocrinol. 2006 Feb;188(2):179-92.

3.

Human astrocytes are resistant to Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.

Song JH, Bellail A, Tse MC, Yong VW, Hao C.

J Neurosci. 2006 Mar 22;26(12):3299-308. Erratum in: J Neurosci. 2006 May 3;26(18):4983.

5.

Activation of Fas ligand/receptor system kills ovarian cancer cell lines by an apoptotic mechanism.

Ghahremani M, Foghi A, Dorrington JH.

Gynecol Oncol. 1998 Aug;70(2):275-81.

PMID:
9740705
6.

HPMA copolymer-bound doxorubicin induces apoptosis in human ovarian carcinoma cells by a Fas-independent pathway.

Malugin A, Kopecková P, Kopecek J.

Mol Pharm. 2004 May-Jun;1(3):174-82.

PMID:
15981920
7.

Apoptosis of bovine ovarian surface epithelial cells by Fas antigen/Fas ligand signaling.

Margalit KA, Cowan RG, Harman RM, Quirk SM.

Reproduction. 2005 Nov;130(5):751-8.

8.

Gonadotropin-stimulated epidermal growth factor receptor expression in human ovarian surface epithelial cells: involvement of cyclic AMP-dependent exchange protein activated by cAMP pathway.

Choi JH, Chen CL, Poon SL, Wang HS, Leung PC.

Endocr Relat Cancer. 2009 Mar;16(1):179-88. doi: 10.1677/ERC-07-0238. Epub 2008 Nov 20.

10.
12.

Susceptibility to FAS-induced apoptosis in human nontumoral enterocytes: role of costimulatory factors.

Ruemmele FM, Russo P, Beaulieu J, Dionne S, Levy E, Lentze MJ, Seidman EG.

J Cell Physiol. 1999 Oct;181(1):45-54.

PMID:
10457352
13.

Isoliquiritigenin induces apoptosis by depolarizing mitochondrial membranes in prostate cancer cells.

Jung JI, Lim SS, Choi HJ, Cho HJ, Shin HK, Kim EJ, Chung WY, Park KK, Park JH.

J Nutr Biochem. 2006 Oct;17(10):689-96. Epub 2005 Dec 9.

PMID:
16517140
14.

Mitomycin C induces apoptosis via Fas/FasL dependent pathway and suppression of IL-18 in cervical carcinoma cells.

Kang YH, Lee KA, Ryu CJ, Lee HG, Lim JS, Park SN, Paik SG, Yoon DY.

Cancer Lett. 2006 Jun 8;237(1):33-44. Epub 2005 Jul 12.

PMID:
16019139
15.

Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.

Xue C, Lan-Lan W, Bei C, Jie C, Wei-Hua F.

Cell Immunol. 2006 Feb;239(2):121-8. Epub 2006 Jun 30. Erratum in: Cell Immunol. 2006 Oct;243(2):127.

PMID:
16808908
16.

Differential expression of apoptosis-related proteins in various cellular components of ameloblastomas.

Luo HY, Yu SF, Li TJ.

Int J Oral Maxillofac Surg. 2006 Aug;35(8):750-5. Epub 2006 May 9.

PMID:
16690252
17.
18.

Bleomycin initiates apoptosis of lung epithelial cells by ROS but not by Fas/FasL pathway.

Wallach-Dayan SB, Izbicki G, Cohen PY, Gerstl-Golan R, Fine A, Breuer R.

Am J Physiol Lung Cell Mol Physiol. 2006 Apr;290(4):L790-L796. Epub 2005 Nov 23.

19.

Luteinizing hormone-induced up-regulation of ErbB-2 is insufficient stimulant of growth and invasion in ovarian cancer cells.

Warrenfeltz SW, Lott SA, Palmer TM, Gray JC, Puett D.

Mol Cancer Res. 2008 Nov;6(11):1775-85. doi: 10.1158/1541-7786.MCR-08-0214.

20.

Irregularly shaped inclusion cysts display increased expression of Ki67, Fas, Fas ligand, and procaspase-3 but relatively little active caspase-3.

Slot KA, de Boer-Brouwer M, Voorendt M, Sie-Go DM, Ghahremani M, Dorrington JH, Teerds KJ.

Int J Gynecol Cancer. 2006 Jan-Feb;16(1):231-9.

PMID:
16445638

Supplemental Content

Support Center